ARECOR ESTABLISHES NEW SCIENTIFIC ADVISORY BOARD OF WORLD LEADING EXPERTS IN ORAL DRUG DELIVERY
Internationally recognised leaders will provide expert technical guidance to support Arecor in its mission to develop a game-changing oral delivery of peptides technology platform
Cambridge, UK,14 July 2025: Arecor Therapeutics plc (AIM: AREC), the biopharmaceutical company advancing today’s therapies to enable healthier lives, today announces the formation of its new Scientific Advisory Board of internationally recognised experts in the fields of oral drug delivery and peptide therapeutics.